Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
December 8, 2022
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
December 7, 2022
Vor Bio Prices Underwritten Offering of Common Stock and Concurrent Private Placement for Aggregate Proceeds of $115.8 Million
December 7, 2022
First AML Patient Successfully Transplanted with Vor Bio’s Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
December 7, 2022
Portal Instruments appoints Dr. Veena Rao, PhD, as Chief Business Officer
December 5, 2022
IDEAYA Biosciences Receives Fast Track Designation for Darovasertib Combination Therapy with Crizotinib for the Treatment of Metastatic Uveal Melanoma
December 2, 2022
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
December 1, 2022
Womens Health Advocate Amy Schumer Joins TMRW Life Sciences as Investor
December 1, 2022
Cidara Therapeutics Announces Issuance of First U.S. Patent for CD388
December 1, 2022
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
November 30, 2022
Dianthus Therapeutics Announces First Participant Dosed in Phase 1 Trial of DNTH103, a Selective Inhibitor of the Classical Complement Pathway
« Previous Page
1
…
14
15
16
17
18
…
118
Next Page »